Telomerase-Mediated Strategy for Overcoming Non–Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
Standard and targeted cancer therapies for late-stage cancer patients almost universally fail due to tumor heterogeneity/plasticity and intrinsic or acquired drug resistance. We used the telomerase substrate nucleoside precursor, 6-thio-2′-deoxyguanosine (6-thio-dG), to target telomerase-expressing...
Main Authors: | Ilgen Mender, Ryan LaRanger, Krishna Luitel, Michael Peyton, Luc Girard, Tsung-Po Lai, Kimberly Batten, Crystal Cornelius, Maithili P. Dalvi, Michael Ramirez, Wenting Du, Lani F. Wu, Steven J. Altschuler, Rolf Brekken, Elisabeth D. Martinez, John D. Minna, Woodring E. Wright, Jerry W. Shay |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-08-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558618302525 |
Similar Items
-
Telomerase Repeated Amplification Protocol (TRAP)
by: ilgen Mender, et al.
Published: (2015-11-01) -
Regulation of the Human Telomerase Gene TERT by Telomere Position Effect-Over Long Distances (TPE-OLD): Implications for Aging and Cancer.
by: Wanil Kim, et al.
Published: (2016-12-01) -
697 Telomerase-driven telomeric DNA modification in cancer cells leads to efficient induction of cGAS-mediated innate and adoptive immune responses
by: Silvia Siteni, et al.
Published: (2021-11-01) -
Telomere Restriction Fragment (TRF) Analysis
by: ilgen Mender, et al.
Published: (2015-11-01) -
Telomere Dysfunction Induced Foci (TIF) Analysis
by: ilgen Mender, et al.
Published: (2015-11-01)